Changjun Wang, Ying Xu, Yan Lin, Feng Mao, Jinghong Guan, Songjie Shen, Yanna Zhang, Xiaohui Zhang, Xuejing Wang, Ying Zhong, Bo Pan, Yan Li, Xin Huang, Li Peng, Xi Cao, Ru Yao, Jie Lang, Yidong Zhou, Qiang Sun. "Pyrotinib plus nab-paclitaxel as adjuvant therapy for patients with N0/N1mi, HER2-positive early-stage breast cancer: 3-year iDFS results of the phase II PHAEDRA trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.533